SG Americas Securities LLC Sells 6,310 Shares of Ingevity Co. (NYSE:NGVT)

SG Americas Securities LLC trimmed its stake in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 33.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,522 shares of the company's stock after selling 6,310 shares during the period. SG Americas Securities LLC's holdings in Ingevity were worth $510,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. Amalgamated Bank lifted its position in shares of Ingevity by 2.4% in the third quarter. Amalgamated Bank now owns 10,667 shares of the company's stock worth $416,000 after purchasing an additional 246 shares in the last quarter. First Horizon Advisors Inc. lifted its position in Ingevity by 45.9% during the 3rd quarter. First Horizon Advisors Inc. now owns 862 shares of the company's stock worth $34,000 after buying an additional 271 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of Ingevity by 1.2% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 25,739 shares of the company's stock worth $1,004,000 after buying an additional 313 shares during the last quarter. KBC Group NV grew its holdings in shares of Ingevity by 50.8% in the 3rd quarter. KBC Group NV now owns 1,574 shares of the company's stock valued at $61,000 after acquiring an additional 530 shares in the last quarter. Finally, Louisiana State Employees Retirement System increased its position in shares of Ingevity by 3.5% in the third quarter. Louisiana State Employees Retirement System now owns 17,600 shares of the company's stock valued at $686,000 after acquiring an additional 600 shares during the last quarter. 91.59% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, BMO Capital Markets increased their price target on Ingevity from $40.00 to $47.00 and gave the company a "market perform" rating in a research report on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $52.17.

Ingevity Stock Performance

NYSE:NGVT traded down $0.28 during mid-day trading on Wednesday, hitting $44.55. The stock had a trading volume of 160,745 shares, compared to its average volume of 200,606. Ingevity Co. has a twelve month low of $30.90 and a twelve month high of $56.29. The company has a debt-to-equity ratio of 6.52, a quick ratio of 1.04 and a current ratio of 1.76. The stock has a market cap of $1.62 billion, a price-to-earnings ratio of -2.87 and a beta of 1.64. The company's 50 day simple moving average is $43.84 and its 200 day simple moving average is $40.98.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.